BALAXI PHARMACEUTICALS LIMITED — Important, 31-07-2025: Updates

Balaxi Pharmaceuticals, an international wholesale pharma distributor with 100% export turnover, reported FY25 revenue of **₹60.99 Cr** and net worth of **₹127.85 Cr**. The company plans to launch its first manufacturing plant in H1 FY26, signaling a strategic shift. Operationally, it shows robust governance with nil complaints from stakeholders and no safety incidents. A significant 96.04% of input materials are sourced from Indian MSMEs. Accounts payable days improved to 64. A minor penalty of **₹0.01 Cr** was incurred for a procedural appointment delay, while environmental compliance remains strong, consistent with its non-manufacturing model.